Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Basal Cell | 5 | 2023 | 545 | 1.950 |
Why?
|
| Cosmetic Techniques | 5 | 2021 | 135 | 1.880 |
Why?
|
| Mohs Surgery | 6 | 2023 | 197 | 1.720 |
Why?
|
| Skin Neoplasms | 11 | 2023 | 5686 | 1.580 |
Why?
|
| Keratinocytes | 3 | 2022 | 798 | 0.780 |
Why?
|
| Dermatology | 3 | 2022 | 872 | 0.770 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2022 | 4034 | 0.750 |
Why?
|
| Isotretinoin | 2 | 2017 | 114 | 0.720 |
Why?
|
| Warts | 1 | 2019 | 68 | 0.700 |
Why?
|
| Nose Neoplasms | 1 | 2021 | 246 | 0.680 |
Why?
|
| Dermabrasion | 1 | 2017 | 13 | 0.630 |
Why?
|
| Chemexfoliation | 1 | 2017 | 11 | 0.620 |
Why?
|
| Cancer Care Facilities | 1 | 2020 | 402 | 0.620 |
Why?
|
| Dermatologic Agents | 2 | 2017 | 278 | 0.580 |
Why?
|
| Drug Storage | 1 | 2016 | 51 | 0.560 |
Why?
|
| Skin Transplantation | 1 | 2021 | 1074 | 0.540 |
Why?
|
| Syringes | 1 | 2016 | 56 | 0.540 |
Why?
|
| Drug Contamination | 1 | 2016 | 147 | 0.500 |
Why?
|
| Organizational Objectives | 1 | 2016 | 438 | 0.490 |
Why?
|
| Laser Therapy | 2 | 2017 | 1072 | 0.460 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 491 | 0.450 |
Why?
|
| Lidocaine | 1 | 2016 | 544 | 0.440 |
Why?
|
| Surgical Flaps | 1 | 2021 | 1640 | 0.430 |
Why?
|
| Skin | 4 | 2020 | 4364 | 0.430 |
Why?
|
| Epinephrine | 1 | 2016 | 792 | 0.430 |
Why?
|
| Fellowships and Scholarships | 2 | 2021 | 1076 | 0.420 |
Why?
|
| Melanoma | 2 | 2021 | 5510 | 0.420 |
Why?
|
| Patients | 1 | 2019 | 900 | 0.420 |
Why?
|
| Motivation | 2 | 2019 | 1971 | 0.410 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 2924 | 0.410 |
Why?
|
| Carcinoma | 1 | 2021 | 2375 | 0.350 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 985 | 0.330 |
Why?
|
| Health Behavior | 1 | 2021 | 2636 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 2734 | 0.300 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 11031 | 0.260 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 2291 | 0.260 |
Why?
|
| Skin Diseases | 3 | 2019 | 1065 | 0.250 |
Why?
|
| Internship and Residency | 4 | 2021 | 5788 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 6 | 2020 | 7279 | 0.220 |
Why?
|
| Cicatrix | 2 | 2017 | 764 | 0.200 |
Why?
|
| Photopheresis | 1 | 2010 | 24 | 0.190 |
Why?
|
| Protective Clothing | 1 | 2021 | 102 | 0.190 |
Why?
|
| Hutchinson's Melanotic Freckle | 1 | 2020 | 19 | 0.180 |
Why?
|
| Organizations, Nonprofit | 1 | 2020 | 104 | 0.180 |
Why?
|
| Sunscreening Agents | 1 | 2021 | 132 | 0.180 |
Why?
|
| Tarlov Cysts | 1 | 2009 | 13 | 0.180 |
Why?
|
| Adenocarcinoma, Sebaceous | 1 | 2019 | 21 | 0.180 |
Why?
|
| Neuromuscular Agents | 1 | 2021 | 134 | 0.180 |
Why?
|
| Botulinum Toxins | 1 | 2021 | 191 | 0.170 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2019 | 39 | 0.170 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2021 | 213 | 0.160 |
Why?
|
| Genes, p16 | 1 | 2008 | 157 | 0.160 |
Why?
|
| Cellulitis | 1 | 2018 | 206 | 0.140 |
Why?
|
| Humans | 29 | 2023 | 744343 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 847 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2020 | 709 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 2699 | 0.130 |
Why?
|
| Thoracic Vertebrae | 1 | 2009 | 608 | 0.120 |
Why?
|
| Self Efficacy | 1 | 2018 | 616 | 0.120 |
Why?
|
| Physician's Role | 1 | 2021 | 943 | 0.120 |
Why?
|
| Body Image | 1 | 2019 | 610 | 0.120 |
Why?
|
| Patient Education as Topic | 2 | 2021 | 2278 | 0.120 |
Why?
|
| Accreditation | 1 | 2016 | 450 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2019 | 1119 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 3616 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1782 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2019 | 2539 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 1425 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2018 | 1158 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2019 | 2682 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2266 | 0.090 |
Why?
|
| Reoperation | 1 | 2020 | 4201 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2021 | 77449 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2725 | 0.090 |
Why?
|
| Aged | 5 | 2021 | 163280 | 0.080 |
Why?
|
| United States | 4 | 2021 | 69872 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2459 | 0.080 |
Why?
|
| Male | 9 | 2021 | 350118 | 0.080 |
Why?
|
| Veterans | 1 | 2021 | 2519 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3610 | 0.080 |
Why?
|
| Quality of Life | 2 | 2019 | 12804 | 0.070 |
Why?
|
| Middle Aged | 6 | 2021 | 213383 | 0.070 |
Why?
|
| Collagen Type XI | 1 | 2006 | 20 | 0.070 |
Why?
|
| Gene Expression | 1 | 2010 | 7799 | 0.070 |
Why?
|
| Collagen Type IX | 1 | 2006 | 20 | 0.070 |
Why?
|
| Biopsy | 1 | 2019 | 6756 | 0.070 |
Why?
|
| Receptors, Mitogen | 1 | 2006 | 62 | 0.070 |
Why?
|
| Emotions | 1 | 2019 | 2661 | 0.070 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2006 | 103 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.070 |
Why?
|
| Wound Healing | 1 | 2017 | 2785 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2019 | 4687 | 0.070 |
Why?
|
| Risk | 1 | 2018 | 9687 | 0.070 |
Why?
|
| Curriculum | 1 | 2019 | 3605 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 57776 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7785 | 0.060 |
Why?
|
| Female | 9 | 2021 | 380194 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2016 | 3743 | 0.060 |
Why?
|
| Patient Selection | 1 | 2016 | 4215 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.060 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2006 | 215 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5319 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11483 | 0.060 |
Why?
|
| Risk Factors | 2 | 2021 | 72290 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63114 | 0.050 |
Why?
|
| Pamphlets | 1 | 2021 | 75 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 20947 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 12072 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2006 | 1095 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 1660 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2006 | 1036 | 0.040 |
Why?
|
| Beauty | 1 | 2018 | 42 | 0.040 |
Why?
|
| Ohio | 1 | 2019 | 337 | 0.040 |
Why?
|
| Injections | 1 | 2021 | 840 | 0.040 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2010 | 207 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 214055 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2021 | 559 | 0.040 |
Why?
|
| Florida | 1 | 2019 | 435 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 647 | 0.040 |
Why?
|
| Skin Aging | 1 | 2018 | 127 | 0.040 |
Why?
|
| Happiness | 1 | 2018 | 170 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2010 | 1950 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 56430 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2010 | 1880 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 893 | 0.030 |
Why?
|
| Face | 1 | 2021 | 994 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1284 | 0.030 |
Why?
|
| Cell Separation | 1 | 2010 | 1751 | 0.030 |
Why?
|
| Video Recording | 1 | 2019 | 949 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 2886 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.030 |
Why?
|
| Reward | 1 | 2018 | 941 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.030 |
Why?
|
| Monocytes | 1 | 2010 | 2596 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 5974 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2021 | 2531 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 2957 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 4161 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8664 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2021 | 3229 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3558 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2006 | 134 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2006 | 151 | 0.020 |
Why?
|
| Protein Binding | 1 | 2008 | 9386 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2018 | 9849 | 0.020 |
Why?
|
| Osteochondrodysplasias | 1 | 2006 | 183 | 0.020 |
Why?
|
| Decision Making | 1 | 2018 | 3887 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2019 | 53288 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 1866 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13033 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 3240 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14722 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 19229 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 85781 | 0.010 |
Why?
|
| Heterozygote | 1 | 2006 | 2804 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29063 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20129 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11366 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 12951 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 18029 | 0.000 |
Why?
|
| Mutation | 1 | 2006 | 29786 | 0.000 |
Why?
|
| Mice | 1 | 2006 | 81183 | 0.000 |
Why?
|
| Animals | 1 | 2006 | 168757 | 0.000 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_